Back to Journals » OncoTargets and Therapy » Volume 10

Crizotinib, a MET inhibitor, inhibits growth, migration, and invasion of breast cancer cells in vitro and synergizes with chemotherapeutic agents

Total article views   HTML views PDF downloads Totals
14,288 Dovepress* 11,319+ 1,167 12,486
PubMed Central* 2,969 524 3,493
Totals 14,288 1,691 15,979
*Since 5 October 2017
Total mentioned Facebook Delicious Reddit Twitter Others
1 0 0 0 0 1

View citations on PubMed Central and Google Scholar